CN Stock MarketDetailed Quotes

603367 Cisen Pharmaceutical

Watchlist
  • 14.00
  • +0.24+1.74%
Market Closed Dec 27 15:00 CST
6.34BMarket Cap11.99P/E (TTM)

Cisen Pharmaceutical Key Stats

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
Total operating revenue
-6.47%3B
-6.72%2.07B
1.28%1.15B
9.75%4.46B
10.23%3.21B
19.12%2.22B
30.43%1.13B
7.49%4.07B
5.61%2.91B
1.74%1.86B
Operating revenue
-6.47%3B
-6.72%2.07B
1.28%1.15B
9.75%4.46B
10.23%3.21B
19.12%2.22B
30.43%1.13B
7.49%4.07B
5.61%2.91B
1.74%1.86B
Other operating revenue
----
-9.24%3.33M
----
-33.81%11.14M
----
20.51%3.67M
----
74.86%16.83M
----
-35.44%3.05M
Total operating cost
-6.66%2.62B
-7.19%1.8B
-1.01%954.82M
4.01%3.87B
7.34%2.8B
15.58%1.94B
26.22%964.57M
5.11%3.72B
3.36%2.61B
1.55%1.68B
Operating cost
-6.78%1.29B
-11.65%874.86M
3.21%434.45M
2.78%1.84B
8.90%1.38B
17.87%990.27M
7.12%420.95M
6.21%1.79B
7.03%1.27B
8.98%840.16M
Operating tax surcharges
-13.87%36.48M
-16.94%25.39M
-10.71%14M
7.25%59.38M
7.14%42.36M
21.97%30.57M
32.51%15.68M
10.05%55.37M
7.29%39.53M
0.28%25.07M
Operating expense
-13.30%820.79M
-8.20%599.25M
-9.17%340.42M
2.20%1.33B
5.03%946.67M
17.72%652.8M
56.88%374.77M
4.74%1.31B
-2.24%901.35M
-9.90%554.56M
Administration expense
9.79%224.84M
8.78%139.11M
8.55%76.35M
12.60%292.41M
10.98%204.79M
3.94%127.88M
12.41%70.34M
13.05%259.7M
27.79%184.53M
41.22%123.03M
Financial expense
6.26%-23.75M
-1.58%-17.18M
-17.30%-10.48M
-20.79%-33.67M
-12.77%-25.33M
-14.63%-16.92M
-27.44%-8.94M
-206.86%-27.88M
-247.50%-22.46M
-313.69%-14.76M
-Interest expense (Financial expense)
15.40%5.68M
-11.64%2.69M
20.13%1.35M
53.34%6.59M
56.13%4.93M
22.26%3.04M
-81.59%1.12M
-29.56%4.29M
-36.11%3.16M
-32.36%2.49M
-Interest Income (Financial expense)
1.39%-28.65M
-1.06%-20.05M
-22.68%-12.05M
-21.18%-41.59M
-9.60%-29.06M
-11.92%-19.83M
44.41%-9.82M
-94.22%-34.32M
-111.42%-26.51M
-117.78%-17.72M
Research and development
6.61%272.31M
15.25%179.09M
9.05%100.07M
11.85%374.88M
5.60%255.42M
3.33%155.39M
41.37%91.77M
0.25%335.17M
-1.84%241.88M
-4.73%150.39M
Credit Impairment Loss
-65.40%-5.29M
-169.23%-8.39M
-83.20%-12.54M
82.11%-2.34M
80.61%-3.2M
73.00%-3.12M
0.24%-6.85M
-320.85%-13.06M
-578.28%-16.48M
-82.68%-11.55M
Asset Impairment Loss
0.06%-39.59M
-5.58%-37.78M
-56.01%-30.33M
-346.47%-73.5M
-71.20%-39.61M
-140.08%-35.78M
-311.66%-19.44M
22.70%-16.46M
4.12%-23.14M
44.94%-14.9M
Other net revenue
249.92%49.46M
87.78%20.11M
-1,141.00%-11.65M
-119.16%-3.09M
489.98%14.14M
100.37%10.71M
155.98%1.12M
-81.82%16.11M
-105.18%-3.62M
-69.59%5.35M
Fair value change income
181.34%24.84M
-68.18%8.43M
-112.04%-2.08M
-232.56%-10.37M
338.54%8.83M
222.33%26.48M
664.50%17.25M
48.78%-3.12M
-126.97%-3.7M
-45.24%8.21M
Invest income
-19.05%23.64M
17.36%18.31M
57.46%10.84M
136.18%44.12M
24.32%29.2M
29.08%15.6M
430.41%6.89M
-74.24%18.68M
-60.50%23.49M
-42.23%12.09M
-Including: Investment income associates
-99.97%120.55
-99.95%120.55
----
117.58%132.27K
178.51%445.14K
134.43%254.99K
159.88%277.19K
-118.06%-752.52K
-102.88%-567.02K
-321.21%-740.64K
Asset deal income
-97.67%13.29K
-95.66%26.29K
5,811.69%2.52M
-39.03%594.29K
-16.05%571.31K
-11.07%605.21K
-93.74%42.62K
266.72%974.68K
568.49%680.53K
568.49%680.53K
Other revenue
149.98%45.84M
470.68%39.52M
517.56%19.93M
31.98%38.41M
18.14%18.34M
-35.96%6.92M
-39.69%3.23M
-22.05%29.1M
-34.03%15.52M
-28.79%10.81M
Operating profit
3.42%435.81M
-0.11%290.12M
6.74%182.48M
62.54%592.58M
41.71%421.41M
52.57%290.43M
65.01%170.95M
9.02%364.58M
-1.24%297.38M
-3.00%190.36M
Add:Non operating Income
76.84%3.93M
50.35%2.68M
3.26%1.32M
2.88%6.21M
-64.47%2.22M
-49.20%1.78M
-56.55%1.28M
26.60%6.03M
102.40%6.25M
49.27%3.51M
Less:Non operating expense
-47.60%799.25K
-50.60%736.05K
-88.74%104K
-33.81%2.93M
-20.76%1.53M
323.69%1.49M
108.85%923.38K
44.82%4.43M
-17.21%1.93M
-84.19%351.69K
Total profit
3.99%438.94M
0.46%292.06M
7.23%183.69M
62.72%595.86M
39.91%422.11M
50.23%290.72M
61.45%171.31M
8.94%366.19M
-0.06%301.7M
-1.46%193.52M
Less:Income tax cost
34.19%35.59M
-23.02%18.35M
52.58%21.51M
405.97%70.43M
79.37%26.52M
144.27%23.83M
48.68%14.1M
524.20%13.92M
-10.47%14.79M
-29.16%9.76M
Net profit
1.96%403.35M
2.56%273.72M
3.16%162.18M
49.15%525.43M
37.87%395.59M
45.24%266.89M
62.71%157.21M
5.50%352.27M
0.55%286.92M
0.63%183.76M
Net profit from continuing operation
1.96%403.35M
2.56%273.72M
3.16%162.18M
49.15%525.43M
37.87%395.59M
45.24%266.89M
62.71%157.21M
5.50%352.27M
0.55%286.92M
0.63%183.76M
Less:Minority Profit
1.83%5.23M
24.25%3.4M
-150.29%-681.86K
76.75%4.09M
194.96%5.14M
1,036.66%2.74M
1,144.54%1.36M
1,045.39%2.31M
-3,648.92%-5.41M
-201.33%-292.1K
Net profit of parent company owners
1.97%398.12M
2.33%270.32M
4.50%162.86M
48.97%521.34M
33.56%390.45M
43.52%264.15M
61.09%155.85M
4.73%349.96M
2.39%292.33M
0.74%184.05M
Earning per share
Basic earning per share
2.33%0.88
3.45%0.6
5.88%0.36
49.35%1.15
34.38%0.86
41.46%0.58
61.90%0.34
4.05%0.77
1.59%0.64
2.50%0.41
Diluted earning per share
2.33%0.88
3.45%0.6
5.88%0.36
49.35%1.15
34.38%0.86
41.46%0.58
61.90%0.34
4.05%0.77
1.59%0.64
2.50%0.41
Other composite income
81.13%-656.48K
155.90%451.37K
9,924.36%1.76M
360.50%244.78K
-3,803.33%-3.48M
-15.66%-807.5K
-97.48%17.6K
90.08%-93.97K
103.63%93.92K
74.76%-698.17K
Other composite income of parent company owners
81.13%-656.48K
155.90%451.37K
9,924.36%1.76M
360.50%244.78K
-3,803.33%-3.48M
-15.66%-807.5K
-97.48%17.6K
90.08%-93.97K
103.63%93.92K
74.76%-698.17K
Total composite income
2.70%402.7M
3.04%274.17M
4.28%163.95M
49.26%525.67M
36.62%392.11M
45.35%266.08M
61.56%157.22M
5.77%352.18M
1.50%287.01M
1.79%183.06M
Total composite income of parent company owners
2.71%397.46M
2.82%270.77M
5.62%164.63M
49.08%521.58M
32.33%386.97M
43.63%263.34M
59.95%155.87M
5.00%349.86M
3.36%292.42M
1.90%183.35M
Total composite income of minority owners
1.83%5.23M
24.25%3.4M
-150.29%-681.86K
76.75%4.09M
194.96%5.14M
1,036.66%2.74M
1,144.54%1.36M
1,045.39%2.31M
-3,648.92%-5.41M
-201.33%-292.1K
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
Auditor
--
--
--
Daxin Certified Public Accountants (Special General Partnership)
--
--
--
Daxin Certified Public Accountants (Special General Partnership)
--
--
(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022
Total operating revenue -6.47%3B-6.72%2.07B1.28%1.15B9.75%4.46B10.23%3.21B19.12%2.22B30.43%1.13B7.49%4.07B5.61%2.91B1.74%1.86B
Operating revenue -6.47%3B-6.72%2.07B1.28%1.15B9.75%4.46B10.23%3.21B19.12%2.22B30.43%1.13B7.49%4.07B5.61%2.91B1.74%1.86B
Other operating revenue -----9.24%3.33M-----33.81%11.14M----20.51%3.67M----74.86%16.83M-----35.44%3.05M
Total operating cost -6.66%2.62B-7.19%1.8B-1.01%954.82M4.01%3.87B7.34%2.8B15.58%1.94B26.22%964.57M5.11%3.72B3.36%2.61B1.55%1.68B
Operating cost -6.78%1.29B-11.65%874.86M3.21%434.45M2.78%1.84B8.90%1.38B17.87%990.27M7.12%420.95M6.21%1.79B7.03%1.27B8.98%840.16M
Operating tax surcharges -13.87%36.48M-16.94%25.39M-10.71%14M7.25%59.38M7.14%42.36M21.97%30.57M32.51%15.68M10.05%55.37M7.29%39.53M0.28%25.07M
Operating expense -13.30%820.79M-8.20%599.25M-9.17%340.42M2.20%1.33B5.03%946.67M17.72%652.8M56.88%374.77M4.74%1.31B-2.24%901.35M-9.90%554.56M
Administration expense 9.79%224.84M8.78%139.11M8.55%76.35M12.60%292.41M10.98%204.79M3.94%127.88M12.41%70.34M13.05%259.7M27.79%184.53M41.22%123.03M
Financial expense 6.26%-23.75M-1.58%-17.18M-17.30%-10.48M-20.79%-33.67M-12.77%-25.33M-14.63%-16.92M-27.44%-8.94M-206.86%-27.88M-247.50%-22.46M-313.69%-14.76M
-Interest expense (Financial expense) 15.40%5.68M-11.64%2.69M20.13%1.35M53.34%6.59M56.13%4.93M22.26%3.04M-81.59%1.12M-29.56%4.29M-36.11%3.16M-32.36%2.49M
-Interest Income (Financial expense) 1.39%-28.65M-1.06%-20.05M-22.68%-12.05M-21.18%-41.59M-9.60%-29.06M-11.92%-19.83M44.41%-9.82M-94.22%-34.32M-111.42%-26.51M-117.78%-17.72M
Research and development 6.61%272.31M15.25%179.09M9.05%100.07M11.85%374.88M5.60%255.42M3.33%155.39M41.37%91.77M0.25%335.17M-1.84%241.88M-4.73%150.39M
Credit Impairment Loss -65.40%-5.29M-169.23%-8.39M-83.20%-12.54M82.11%-2.34M80.61%-3.2M73.00%-3.12M0.24%-6.85M-320.85%-13.06M-578.28%-16.48M-82.68%-11.55M
Asset Impairment Loss 0.06%-39.59M-5.58%-37.78M-56.01%-30.33M-346.47%-73.5M-71.20%-39.61M-140.08%-35.78M-311.66%-19.44M22.70%-16.46M4.12%-23.14M44.94%-14.9M
Other net revenue 249.92%49.46M87.78%20.11M-1,141.00%-11.65M-119.16%-3.09M489.98%14.14M100.37%10.71M155.98%1.12M-81.82%16.11M-105.18%-3.62M-69.59%5.35M
Fair value change income 181.34%24.84M-68.18%8.43M-112.04%-2.08M-232.56%-10.37M338.54%8.83M222.33%26.48M664.50%17.25M48.78%-3.12M-126.97%-3.7M-45.24%8.21M
Invest income -19.05%23.64M17.36%18.31M57.46%10.84M136.18%44.12M24.32%29.2M29.08%15.6M430.41%6.89M-74.24%18.68M-60.50%23.49M-42.23%12.09M
-Including: Investment income associates -99.97%120.55-99.95%120.55----117.58%132.27K178.51%445.14K134.43%254.99K159.88%277.19K-118.06%-752.52K-102.88%-567.02K-321.21%-740.64K
Asset deal income -97.67%13.29K-95.66%26.29K5,811.69%2.52M-39.03%594.29K-16.05%571.31K-11.07%605.21K-93.74%42.62K266.72%974.68K568.49%680.53K568.49%680.53K
Other revenue 149.98%45.84M470.68%39.52M517.56%19.93M31.98%38.41M18.14%18.34M-35.96%6.92M-39.69%3.23M-22.05%29.1M-34.03%15.52M-28.79%10.81M
Operating profit 3.42%435.81M-0.11%290.12M6.74%182.48M62.54%592.58M41.71%421.41M52.57%290.43M65.01%170.95M9.02%364.58M-1.24%297.38M-3.00%190.36M
Add:Non operating Income 76.84%3.93M50.35%2.68M3.26%1.32M2.88%6.21M-64.47%2.22M-49.20%1.78M-56.55%1.28M26.60%6.03M102.40%6.25M49.27%3.51M
Less:Non operating expense -47.60%799.25K-50.60%736.05K-88.74%104K-33.81%2.93M-20.76%1.53M323.69%1.49M108.85%923.38K44.82%4.43M-17.21%1.93M-84.19%351.69K
Total profit 3.99%438.94M0.46%292.06M7.23%183.69M62.72%595.86M39.91%422.11M50.23%290.72M61.45%171.31M8.94%366.19M-0.06%301.7M-1.46%193.52M
Less:Income tax cost 34.19%35.59M-23.02%18.35M52.58%21.51M405.97%70.43M79.37%26.52M144.27%23.83M48.68%14.1M524.20%13.92M-10.47%14.79M-29.16%9.76M
Net profit 1.96%403.35M2.56%273.72M3.16%162.18M49.15%525.43M37.87%395.59M45.24%266.89M62.71%157.21M5.50%352.27M0.55%286.92M0.63%183.76M
Net profit from continuing operation 1.96%403.35M2.56%273.72M3.16%162.18M49.15%525.43M37.87%395.59M45.24%266.89M62.71%157.21M5.50%352.27M0.55%286.92M0.63%183.76M
Less:Minority Profit 1.83%5.23M24.25%3.4M-150.29%-681.86K76.75%4.09M194.96%5.14M1,036.66%2.74M1,144.54%1.36M1,045.39%2.31M-3,648.92%-5.41M-201.33%-292.1K
Net profit of parent company owners 1.97%398.12M2.33%270.32M4.50%162.86M48.97%521.34M33.56%390.45M43.52%264.15M61.09%155.85M4.73%349.96M2.39%292.33M0.74%184.05M
Earning per share
Basic earning per share 2.33%0.883.45%0.65.88%0.3649.35%1.1534.38%0.8641.46%0.5861.90%0.344.05%0.771.59%0.642.50%0.41
Diluted earning per share 2.33%0.883.45%0.65.88%0.3649.35%1.1534.38%0.8641.46%0.5861.90%0.344.05%0.771.59%0.642.50%0.41
Other composite income 81.13%-656.48K155.90%451.37K9,924.36%1.76M360.50%244.78K-3,803.33%-3.48M-15.66%-807.5K-97.48%17.6K90.08%-93.97K103.63%93.92K74.76%-698.17K
Other composite income of parent company owners 81.13%-656.48K155.90%451.37K9,924.36%1.76M360.50%244.78K-3,803.33%-3.48M-15.66%-807.5K-97.48%17.6K90.08%-93.97K103.63%93.92K74.76%-698.17K
Total composite income 2.70%402.7M3.04%274.17M4.28%163.95M49.26%525.67M36.62%392.11M45.35%266.08M61.56%157.22M5.77%352.18M1.50%287.01M1.79%183.06M
Total composite income of parent company owners 2.71%397.46M2.82%270.77M5.62%164.63M49.08%521.58M32.33%386.97M43.63%263.34M59.95%155.87M5.00%349.86M3.36%292.42M1.90%183.35M
Total composite income of minority owners 1.83%5.23M24.25%3.4M-150.29%-681.86K76.75%4.09M194.96%5.14M1,036.66%2.74M1,144.54%1.36M1,045.39%2.31M-3,648.92%-5.41M-201.33%-292.1K
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ------Unqualified opinion------Unqualified opinion----
Auditor ------Daxin Certified Public Accountants (Special General Partnership)------Daxin Certified Public Accountants (Special General Partnership)----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.